Relapsed Acute Myelogenous Leukemia
4 clinical trials · Condition
◉ Watch Relapsed Acute Myelogenous Leukemia
| Record | Firm | Date |
|---|---|---|
| Open Label NK Cell Infusion (FATE-NK100) With Subq IL-2 in Adults With AML (NCT03081780) | Masonic Cancer Center, University of Minnesota | 2017-04-27 |
| Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia (NCT01743807) | Therapeutic Advances in Childhood Leukemia Consortium | 2014-03-26 |
| T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML) (NCT00939653) | Therapeutic Advances in Childhood Leukemia Consortium | 2009-07-10 |
Track Relapsed Acute Myelogenous Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.